TNFSF10 and glioblastoma: Similarly, it has been shown that TRAIL and HSV-TK-modified MSCs in the presence of GCV significantly reduced tumor growth and increased survival in mice bearing highly malignant glioblastoma multiforme (GBM) (Martinez-Quintanilla et al., 2013).